Long-term experience with Sandimmun Neoral: results in de novo and stable renal transplant patients after 24-month treatment. The German Neoral Study Group. - Suppr | 超能文献

Long-term experience with Sandimmun Neoral: results in de novo and stable renal transplant patients after 24-month treatment. The German Neoral Study Group.

作者信息

Korn A, Färber L, Maibücher A, Buchholz B, Offermann G

机构信息

Universitätsklinikum Benjamin Franklin, Berlin, Germany.

出版信息

Transplant Proc. 1997 Nov;29(7):2945-7. doi: 10.1016/s0041-1345(97)00739-2.

DOI:10.1016/s0041-1345(97)00739-2

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Long-term experience with Sandimmun Neoral: results in de novo and stable renal transplant patients after 24-month treatment. The German Neoral Study Group.

Transplant Proc. 1997 Nov;29(7):2945-7. doi: 10.1016/s0041-1345(97)00739-2.

2

Comparison of efficacy, safety, and tolerability of Neoral vs Sandimmun in de novo renal transplant patients over 24 months' treatment.

Transplant Proc. 1997 Feb-Mar;29(1-2):275-6. doi: 10.1016/s0041-1345(96)00091-7.

3

Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.

Transplant Proc. 1996 Aug;28(4):2187-8.

4

Safety and tolerability of CyA microemulsion formulation (Sandimmun Neoral) in stable renal transplant patients after 24 months of treatment. German Neoral Study Group.

Transplant Proc. 1996 Aug;28(4):2204-6.

5

Conversion from conventional Sandimmun to Neoral therapy in stable renal transplant recipients.

Transplant Proc. 1996 Aug;28(4):2199-201.

6

Neoral vs Sandimmun: interim results of a randomized trial of efficacy and safety in preventing acute rejection in new renal transplant recipients. The U. K. Neoral Study Group.

Transplant Proc. 1997 Feb-Mar;29(1-2):272-3. doi: 10.1016/s0041-1345(96)00089-9.

7

Experience with clinical use of Sandimmun Neoral in renal transplant patients.

Transplant Proc. 1996 Jun;28(3):1356-7.

8

Neoral versus Sandimmune in kidney transplantation.

Transplant Proc. 1998 Aug;30(5):1749-50. doi: 10.1016/s0041-1345(98)00414-x.

9

Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients.

Transpl Int. 1994;7 Suppl 1:S263-6. doi: 10.1111/j.1432-2277.1994.tb01363.x.

10

A double-blind randomized study of Sandimmun Neoral versus Sandimmun in new renal transplant recipients: results after 12 months. The International Sandimmun Neoral Study Group.

Transplant Proc. 1995 Apr;27(2):1849-56.

引用本文的文献

1

Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation.

Pharmacoeconomics. 1998 Dec;14(6):691-708. doi: 10.2165/00019053-199814060-00009.